PANCREATIC CANCER 12/10/06

Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, Frankel WL, Morgan DL, Postier RG, Brackett J, Schmittgen TD. [ABSTRACT]
Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer. 2006 Dec 5; [Epub ahead of print]

Dragovich T, Huberman M, Von Hoff DD, Rowinsky EK, Nadler P, Wood D, Hamilton M, Hage G, Wolf J, Patnaik A. [ABSTRACT]
Erlotinib plus gemcitabine in patients with unresectable pancreatic cancer and other solid tumors: phase IB trial.
Cancer Chemother Pharmacol. 2006 Dec 6; [Epub ahead of print]

Mudali SV, Fu B, Lakkur SS, Luo M, Embuscado EE, Iacobuzio-Donahue CA.[ABSTRACT]
Patterns of EphA2 protein expression in primary and metastatic pancreatic carcinoma and correlation with genetic status.
Clin Exp Metastasis. 2006 Dec 5; [Epub ahead of print]

Bianco C, Giovannetti E, Ciardiello F, Mey V, Nannizzi S, Tortora G, Troiani T, Pasqualetti F, Eckhardt G, de Liguoro M, Ricciardi S, Del Tacca M, Raben D, Cionini L, Danesi R.[ABSTRACT]
Synergistic Antitumor Activity of ZD6474, An Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor Signaling, with Gemcitabine and Ionizing Radiation against Pancreatic Cancer.
Clin Cancer Res. 2006 Dec 1;12(23):7099-107.

Rao MS, Reddy JK. [ABSTRACT]
Pancreatic stem cells: differentiation options.
Stem Cell Rev. 2005 Sep;1(3):265-72.

Chu CS, Xue B, Tu C, Feng ZH, Shi YH, Miao Y, Wen CJ.[ABSTRACT]
NRAGE suppresses metastasis of melanoma and pancreatic cancer in vitro and in vivo.
Cancer Lett. 2006 Nov 29; [Epub ahead of print]